OFFIDANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 686
AS - Asia 431
EU - Europa 428
SA - Sud America 136
AF - Africa 50
Totale 1.731
Nazione #
US - Stati Uniti d'America 672
IT - Italia 152
SG - Singapore 122
BR - Brasile 112
CN - Cina 103
HK - Hong Kong 82
DE - Germania 57
RU - Federazione Russa 56
VN - Vietnam 55
CI - Costa d'Avorio 32
GB - Regno Unito 23
IE - Irlanda 20
SE - Svezia 20
FR - Francia 19
IN - India 17
FI - Finlandia 16
TR - Turchia 16
UA - Ucraina 16
AR - Argentina 14
AT - Austria 13
NL - Olanda 10
DK - Danimarca 9
JP - Giappone 9
MA - Marocco 7
MX - Messico 7
EC - Ecuador 6
ID - Indonesia 6
CA - Canada 5
ZA - Sudafrica 5
SN - Senegal 4
UZ - Uzbekistan 4
BD - Bangladesh 3
ES - Italia 3
HU - Ungheria 3
KR - Corea 3
PL - Polonia 3
BE - Belgio 2
LT - Lituania 2
PE - Perù 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GI - Gibilterra 1
HN - Honduras 1
IQ - Iraq 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RO - Romania 1
Totale 1.731
Città #
Ashburn 137
Dallas 127
Hong Kong 81
Singapore 77
Boardman 41
Abidjan 32
Munich 31
Chandler 26
Ho Chi Minh City 23
Beijing 21
Los Angeles 21
Dublin 20
New York 19
São Paulo 19
Hefei 18
The Dalles 18
Rome 16
Jacksonville 15
Fairfield 14
Moscow 13
Hanoi 12
Milan 12
Wilmington 12
Santa Clara 10
Frankfurt am Main 9
Seattle 9
Turin 9
Turku 9
Buffalo 7
Denver 7
Guangzhou 7
Nuremberg 7
Ancona 6
Bari 6
Brooklyn 6
Chicago 6
Council Bluffs 6
Houston 6
Woodbridge 6
Bologna 5
Cambridge 5
Falconara Marittima 5
Lawrence 5
London 5
Mexico City 5
North Charleston 5
Princeton 5
Amsterdam 4
Brescia 4
Camden 4
Chennai 4
Dakar 4
Helsinki 4
Johannesburg 4
Orem 4
Tashkent 4
Washington 4
Ann Arbor 3
Curitiba 3
Da Nang 3
Guayaquil 3
Holstebro 3
Magnesia ad Sipylum 3
Mumbai 3
Ninh Bình 3
Pescara 3
Rio de Janeiro 3
San Mateo 3
Southwark 3
Wuxi 3
Altamura 2
Ankara 2
Araçatuba 2
Boston 2
Brussels 2
Caraguatatuba 2
Caxias do Sul 2
Centro 2
Columbus 2
Corridonia 2
Fayetteville 2
Florence 2
Foggia 2
Fortaleza 2
Giugliano in Campania 2
Guiyang 2
Haiphong 2
Jequié 2
Jiaxing 2
Kilburn 2
Lima 2
Montesilvano Marina 2
Nanjing 2
New Delhi 2
Ortona 2
Phoenix 2
Poplar 2
Querétaro 2
Quito 2
Quảng Ninh 2
Totale 1.100
Nome #
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 135
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 113
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 93
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 91
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 89
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 86
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 85
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 84
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 78
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 75
Current Main Topics in Multiple Myeloma 70
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy 69
AL amyloidosis: an overview on diagnosis, staging system, and treatment 68
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study 65
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 64
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety 63
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 61
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 57
Long-Term Survival with Multiple Myeloma: An Italian Experience 56
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences 55
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients 54
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management 51
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 47
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 44
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience 26
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 25
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 9
Totale 1.813
Categoria #
all - tutte 7.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 1 5 2 6 3 6 3
2021/202232 2 3 2 1 0 1 5 3 1 2 6 6
2022/202387 5 11 7 3 4 11 0 4 18 0 24 0
2023/2024182 15 5 8 11 22 18 4 5 9 7 23 55
2024/2025549 40 27 21 6 12 33 40 25 130 80 57 78
2025/2026844 145 135 169 174 188 33 0 0 0 0 0 0
Totale 1.813